Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer

International Journal of Cancer

Volumn 135, Issue 11, 2014, Pages 2653-2660

  Wang, Meilin ^a   Chu, Haiyan ^a   Lv, Qiang ^b   Wang, Li ^c   Yuan, Lin ^d   Fu, Guangbo ^a   Tong, Na ^a   Qin, Chao ^b   Yin, Changjun ^b   Zhang, Zhengdong ^a   Xu, Jianfeng ^c,e  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

Bladder cancer; Cumulative effect; Genome wide association study; Susceptibility

Indexed keywords

GLUTATHIONE TRANSFERASE M1; TUMOR MARKER;

ADULT; AGED; ALLELE; AREA UNDER THE CURVE; ARTICLE; ASIAN; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER RISK; CASE CONTROL STUDY; CHINESE; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 3Q; CHROMOSOME 4P; CHROMOSOME 8P; CHROMOSOME 8Q; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GSTM1 GENE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; SLC14A1 GENE; SMOKING; VERY ELDERLY; BLADDER; BLADDER TUMOR; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; HUMAN CHROMOSOME; METABOLISM; POLYMERASE CHAIN REACTION; PROGNOSIS; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84921633018     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28898     Document Type: Article

References (38)

1. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005;6:95-108.
2. Kiemeney LA, Thorlacius S, Sulem P, et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 2008;40: 1307-12.
3. Wu X, Ye Y, Kiemeney LA, et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 2009;41:991-5.
4. Rafnar T, Sulem P, Stacey SN, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 2009;41: 221-7.
5. Kiemeney LA, Sulem P, Besenbacher S, et al. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet 2010;42: 415-9.
6. Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 2010;42:978-84.
7. Garcia-Closas M, Ye Y, Rothman N, et al. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet 2011;20: 4282-9.
8. Rafnar T, Vermeulen SH, Sulem P, et al. European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet 2011;20: 4268-81.
9. Figueroa JD, Ye Y, Siddiq A, et al. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet 2013.
10. Garcia-Closas M, Malats N, Silverman D, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005;366:649-59.
11. Moore LE, Baris DR, Figueroa JD, et al. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis 2011;32: 182-9.
12. Wang M, Zhang W, Yuan L, et al. Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population. Carcinogenesis 2009;30:991-6.
13. Wang S, Tang J, Wang M, et al. Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population. Carcinogenesis 2010;31: 621-4.
14. Wang M, Chu H, Yan F, et al. Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population. Carcinogenesis 2011;32: 872-5.
15. Stern MC, Van Den Berg D, Yuan JM, et al. Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Cancer Epidemiol Biomarkers Prev 2009;18:3057-61.
16. Ma Z, Hu Q, Chen Z, et al. Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a Chinese population. Mol Carcinogenesis 2012.
17. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, et al. Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 2007;25:285-95.
18. Zheng SL, Sun J, Wiklund F, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008;358:910-9.
19. Wang M, Chu H, Li P, et al. Genetic variants in miRNAs predict bladder cancer risk and recurrence. Cancer Res 2012;72:6173-82.
20. Shao J, Gu M, Zhang Z, et al. Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population. Int J Urol 2008;15:216-21.
21. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44: 837-45.
22. Raychaudhuri S, Plenge RM, Rossin EJ, et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet 2009;5: e1000534.
23. Patel JH, Loboda AP, Showe MK, et al. Analysis of genomic targets reveals complex functions of MYC. Nat Rev Cancer 2004;4: 562-8.
24. Sakamoto H, Yoshimura K, Saeki N, et al. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet 2008;40:730-40.
25. Han KR, Seligson DB, Liu X, et al. Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer. J Urol 2004;171: 1117-21.
26. Bahrenberg G, Brauers A, Joost HG, et al. Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem Biophys Res Commun 2000;275:783-8.
27. Dong LM, Potter JD, White E, et al. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 2008;299: 2423-36.
28. Wilson JF, Weale ME, Smith AC, et al. Population genetic structure of variable drug response. Nat Genet 2001;29:265-9.
29. Zhang ZJ, Hao K, Shi R, et al. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a HuGE review and meta-analysis. Am J Epidemiol 2011;173: 847-57.
30. Shayakul C, Hediger MA. The SLC14 gene family of urea transporters. Pflugers Archiv 2004;447: 603-9.
31. Koutros S, Baris D, Fischer A, et al. Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1. Int J Cancer 2013.
32. di Martino E, Tomlinson DC, Knowles MA. A decade of FGF receptor research in bladder cancer: past, present, and future challenges. Adv Urol 2012;2012:429213.
33. Blasco MA. Telomere length, stem cells and aging. Nat Chem Biol 2007;3:640-9.
34. Kader AK, Sun J, Reck BH, et al. Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men after an initial negative biopsy: findings from the REDUCE trial. Eur Urol 2012;62:953-61.
35. Klein RJ, Hallden C, Gupta A, et al. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostatespecific antigen at baseline to predict prostate cancer in unscreened men. Eur Urol 2012;61: 471-7.
36. Nordstrom T, Aly M, Eklund M, et al. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml. Eur Urol 2013.
37. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633-7.
38. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008;452:638-42.